Our Pricing

GLP-1 Weight Loss Injections: Live UK Stock Status

Finding ozempic wegovy mounjaro in stock uk pharmacies has become increasingly challenging during 2024's supply constraints. At Cured Pharmacy, we maintain live stock of all three leading GLP-1 treatments, with transparent pricing and same-day prescriber approval available for eligible patients.

Why GLP-1 Availability Matters in 2024

The unprecedented demand for GLP-1 receptor agonists has created significant supply challenges across UK pharmacies throughout 2024. Many patients report waiting weeks for their prescribed medication, disrupting treatment continuity and weight loss progress. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar works directly with UK wholesalers to secure consistent stock allocation of Mounjaro, Wegovy, and Saxenda.

Treatment interruptions with GLP-1 medications can affect efficacy and increase the risk of side effects when restarting [1]. Maintaining continuous access to your prescribed dose is essential for optimal outcomes. Our real-time stock monitoring system ensures you can order with confidence, knowing your medication will be dispensed within 24 hours of prescriber approval.

Mounjaro (Tirzepatide): The Dual-Action Approach

Mounjaro represents the newest generation of weight loss medication available in the UK, containing tirzepatide—the first dual GIP/GLP-1 receptor agonist licensed by the MHRA. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors simultaneously, producing enhanced metabolic effects [2].

In the landmark SURMOUNT-1 trial, patients receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—the highest efficacy demonstrated by any obesity medication in clinical trials to date [2]. Participants also showed significant improvements in cardiovascular risk markers including blood pressure, triglycerides, and inflammatory markers.

At Cured Pharmacy, Mounjaro is priced from £135.00 per pen, with dosing schedules determined by your UK prescriber during the free online consultation. Most patients begin with the 2.5mg starter dose and gradually titrate upward every four weeks, allowing your body to adjust and minimising gastrointestinal side effects.

Who Can Use Mounjaro?

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your prescriber will assess your full medical history, current medications, and treatment goals before determining suitability. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 cannot use GLP-1 medications.

Wegovy (Semaglutide): Proven Efficacy with Weekly Dosing

Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP clinical trial programme involving over 4,500 participants. In the STEP 1 trial, patients receiving the 2.4mg maintenance dose achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [3].

The medication works by mimicking the natural GLP-1 hormone, which regulates appetite through multiple mechanisms: slowing gastric emptying, reducing food cravings, and enhancing satiety signals in the hypothalamus. Patients typically report feeling fuller after smaller portions and experiencing fewer hunger cues between meals [3].

Wegovy is available at Cured Pharmacy from £135.00 currently discounted from the standard £135.00 price. The treatment follows a structured dose escalation schedule starting at 0.25mg weekly, gradually increasing to the maintenance dose of 2.4mg over 16 weeks. This gradual titration significantly reduces the incidence of nausea and other gastrointestinal side effects commonly associated with GLP-1 medications.

Wegovy vs Ozempic: Understanding the Difference

Both medications contain semaglutide, but Wegovy is specifically licensed for weight management at higher doses (up to 2.4mg), whilst Ozempic is licensed for type 2 diabetes at lower doses (up to 1mg, or 2mg in some cases). Prescribing Ozempic for weight loss constitutes off-label use in the UK. At Cured Pharmacy, our prescribers follow MHRA guidance and prescribe Wegovy for weight management to ensure you receive the appropriate licensed treatment for your condition.

Comparing Your Treatment Options

Choosing between available GLP-1 treatments depends on several factors including your weight loss goals, medical history, budget considerations, and tolerance for injection frequency. Whilst all three medications work through similar mechanisms, their efficacy profiles, side effect patterns, and dosing schedules differ meaningfully.

Mounjaro's dual-receptor mechanism typically produces greater weight loss compared to single-pathway GLP-1 agonists, but comes at a higher price point. Wegovy offers robust efficacy backed by extensive clinical trial data and represents the middle ground in both cost and effectiveness. Saxenda requires daily injections rather than weekly dosing, which some patients find more manageable for maintaining steady medication levels, though others prefer the convenience of once-weekly administration.

Your UK prescriber at Cured Pharmacy will discuss these options during your consultation, considering your individual circumstances, previous weight loss attempts, any contraindications, and realistic treatment expectations. All three medications require commitment to lifestyle modifications including dietary changes and increased physical activity for optimal results.

Managing Side Effects and Treatment Expectations

Gastrointestinal side effects represent the most common adverse reactions with GLP-1 medications, affecting approximately 40-50% of patients to varying degrees [1][3]. Nausea, constipation, diarrhoea, and occasional vomiting typically occur during dose escalation phases and usually diminish within 4-8 weeks as your body adjusts to the medication.

To minimise these effects, our prescribers recommend several evidence-based strategies: eating smaller, more frequent meals rather than large portions; avoiding high-fat and heavily processed foods which slow digestion further; staying well-hydrated throughout the day; and taking the injection at a consistent time each week, preferably in the evening after your main meal. If side effects become intolerable, your prescriber can slow the dose escalation schedule or temporarily maintain a lower dose until tolerance improves.

Realistic weight loss expectations are essential for treatment satisfaction. Clinical trials demonstrate that maximum weight loss typically occurs between 60-72 weeks of continuous treatment [2][3]. Most patients lose 1-2 pounds per week during the active weight loss phase, with results varying based on starting weight, adherence to lifestyle modifications, and individual metabolic factors. Patients who combine GLP-1 treatment with structured dietary changes and regular physical activity consistently achieve superior outcomes compared to medication alone.

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing adequate hydration, visual changes, or signs of pancreatitis including pain radiating to your back. Contact your Cured Pharmacy prescriber if side effects interfere with daily activities, if you're not losing weight after 12 weeks at the maintenance dose, or if you have questions about continuing treatment long-term. Our clinical team remains available throughout your treatment journey to adjust dosing, manage side effects, or discuss alternative options if needed.

How to Order from Cured Pharmacy

Ordering GLP-1 weight loss injections from Cured Pharmacy follows a straightforward, fully regulated process that meets all GPhC and MHRA requirements. Begin by completing our free online consultation questionnaire, which takes under three minutes and covers your medical history, current medications, previous weight loss attempts, and treatment goals. A UK-registered prescriber reviews your submission, typically within 2-4 hours during business hours.

If approved, your prescription is sent electronically to our dispensary where our pharmacist team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), verifies the prescription and prepares your medication. We use 100% discreet packaging with no external markings indicating contents, and all orders ship via tracked courier for next-day delivery across the UK. You'll receive tracking information via SMS and email once your order is dispatched.

Our transparent pricing model means you see the exact cost before starting your consultation—no hidden fees or surprise charges at checkout. Prices include the medication, prescriber consultation, and UK delivery. For ongoing treatment, we offer a convenient repeat prescription service where your prescriber can approve refills without requiring a new consultation each time, provided your treatment remains stable and appropriate.

Stock Guarantee and Patient Support

Unlike many UK pharmacies currently experiencing intermittent stock issues, Cured Pharmacy maintains dedicated allocation agreements with licensed UK wholesalers to ensure continuous availability. If a specific strength is temporarily unavailable, our team contacts you immediately to discuss alternatives rather than leaving you waiting indefinitely. Our patient support line (+44 116 4646009) operates during extended hours to answer questions about administration technique, side effect management, or treatment adjustments. We're committed to supporting your weight loss journey from initial consultation through to achieving and maintaining your goal weight.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., Lingvay, I., & STEP 2 Study Group. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
4. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications. Cured Pharmacy operates under GPhC registration 9012511 with superintendent pharmacist Tarun Kumar (GPhC 2233073).